… the 6th Annual Cytokine-Based Drug Development Summit being held May 15 …

… specifically designed for protein degrader drug development. In today’s fast-evolving …

… to accelerate patient-focused drug development research. In this … toughest questions in drug development and reimbursement today.” … accelerating patient-focused drug development.” Brett Kleger - … for patient-focused drug development research available today. …

… , there is potential to disrupt drug development costs and drug prices, with …

… .” Better models for research and drug development Beyond transplantation, the breakthrough offers …

… to health care and drug development wouldn’t suffice. … it reshaped the entire drug development landscape. mRNA technology … valuable framework for future drug development. Regulation can still … a phenomenal acceleration in drug development, but the real …

In an interview with Pharmaceutical Commerce, a session leader from “U.S. Pharmaceutical Transitions: What’s Next?” shared key insights on the current and future state of the market. The conversation highlighted the rapid growth of specialty …

NanoViricides (NYSE-A:NNVC) said it is moving forward with the development of a drug to treat measles, as US health officials report a continuing rise in infections amid declining vaccination rates. The Shelton, Connecticut-based biotechnology firm said it …

… latest advances in drug development, particularly with … drug development Despite the advancements, obesity research and drug development … Fortunately, advances in drug development, especially in … that integrates innovative drug development, personalised care …

… an update on its Measles drug development program, highlighting the potential of …